EMEA-002705-PIP02-19-M01
EMEA-002705-PIP02-19-M01
EMEA-002705-PIP02-19-M01
EMEA-002763-PIP01-20-M01
EMEA-002776-PIP01-20-M02
Human medicines European public assessment report (EPAR): Rixubis, nonacog gamma, Date of authorisation: 19/12/2014, Revision: 12, Status: Authorised
Scientific guidelines with summary-of-product-characteristics recommendations
List of medicinal products under additional monitoring
List of medicinal products under additional monitoring
The role of members representing patients' and healthcare professionals' organisations on EMA scientific committees
Human medicines European public assessment report (EPAR): Vaniqa, eflornithine, Date of authorisation: 19/03/2001, Revision: 24, Status: Authorised
Minutes of the PRAC meeting on 30 September - 03 October 2024